Effects of Peroxisome Proliferator-Activated Receptors, Dietary Fat Intakes and Gene–Diet Interactions on Peak Particle Diameters of Low-Density Lipoproteins

Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

William T. Friedewald, Robert I. Levy, Donald S. Fredrickson · Clinical Chemistry · 1972 · 32.1K citations

Lipid Analysis, Hyperlipidemia, Direct Procedure +19

Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)

Scott M. Grundy, Diane M. Becker, Luther T. Clark et al. · Civil War Book Review · 2002 · 12.2K citations

Cardiovascular Disease, High Blood Cholesterol, Hyperlipidemia +4

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.

Peter Tontonoz, E Hu, Reed A. Graves et al. · Genes & Development · 1994 · 2.2K citations · Full text

Mppar Gamma 2, Adipokines, Metabolic Syndrome +17

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

M A Austin, Mary‐Claire King, K M Vranizan et al. · Circulation · 1990 · 1.4K citations · Full text

Genetics, Nuclear Families, Genetic Epidemiology +20

A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

Samir S. Deeb, Lluís Fajas, Masami Nemoto et al. · Nature Genetics · 1998 · 1.3K citations · Full text

Insulin Resistance, Metabolic Syndrome, Molecular Pharmacology +14